未登录 Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution 吸入型干扰素-β1a对SARS-CoV-2多样性和进化的影响 Edelstein, Gregory E.; Sass, Tatum N.; Deo, Rinki; Glover, Owen T.; Boucau, Julie; Jaganathan, Prasanna; Chew, Kara W.; Giganti, Mark J.; Hughes, Michael D.; Moser, Carlee; Javan, Arzhang Cyrus; Fletcher, Courtney V.; McCarthy, Caitlyn; Wohl, David A.; Daar, Eric S.; Eron, Joseph J.; Currier, Judith S.; Singh, Upinder; Smith, Davey M.; Fischer, William; Barczak, Amy K.; Choudhary, Manish C.; Li, Jonathan Z. 分享 收藏
分享 收藏
Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2-LTR Circles Over 12 Weeks 使用度鲁特韦和/或马拉维若进行抗逆转录病毒疗法强化，并未影响12周内HIV-1细胞相关DNA、RNA及2-LTR环。 Reed, Jonathan C.; Hall, Luke; McKhann, Ashley; Kwak, Ginger; Goecker, Erin A.; Coombs, Robert W.; Chen, Huichao; Roa, Jhoanna; Vecchio, Alyssa; Daar, Eric S.; Hunt, Peter W.; Marra, Christina M.; Campbell, Thomas B.; Ma, Qing; Swaminathan, Shobha; Macatangay, Bernard J. C.; Morse, Gene D.; Miller, Thomas; Rusin, David; Ha, Belinda; Alston-Smith, Beverly; Paul, Robert; Letendre, Scott L.; Spudich, Serena S.; Greninger, Alexander L. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness 2025年美国传染病学会关于COVID-19治疗和管理临床实践指南更新：Pemivibart用于暴露前预防，Vilobelimab用于危重疾病，Abatacept或Infliximab用于严重或危重疾病 Bhimraj, Adarsh; Falck-Ytter, Yngve; Baden, Lindsey R.; Bedimo, Roger; Cawcutt, Kelly; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Kim, Arthur Y.; Li, Jonathan Z.; MacBrayne, Christine; Martin, Greg S.; Nadig, Nandita; Nakamura, Mari M.; Pearson, Jeffrey C.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Shumaker, Amy Hirsch; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody Therapy 肌肉内或静脉内给予抗病毒单克隆抗体疗法快速清除可培养的SARS-CoV-2 Deo, Rinki; Choudhary, Manish C.; Glover, Owen T.; Ignacio, Rachel Bender; Boucau, Julie; Chew, Kara W.; Moser, Carlee; Currier, Judith S.; Eron, Joseph J.; Javan, Arzhang Cyrus; Giganti, Mark J.; Aga, Evgenia; Gibbs, Michael; Cohen, Taylor; Streicher, Katie; Soboleva, Karina; Fletcher, Courtney, V; Daar, Eric S.; Greninger, Alexander L.; Coombs, Robert W.; Fischer, William; Hughes, Michael D.; Smith, Davey; Wohl, David Alain; Barczak, Amy K.; Li, Jonathan Z. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Abatacept 2025年美国传染病学会关于COVID-19治疗和管理的临床实践指南更新：Abatacept Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Infliximab 2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新：Infliximab Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; Macbrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab 2025年美国传染病学会关于COVID-19治疗与管理的临床实践指南更新：Vilobelimab Nadig, Nandita; Bhimraj, Adarsh; Cawcutt, Kelly; Chiotos, Kathleen; Dzierba, Amy L.; Kim, Arthur Y.; Martin, Greg S.; Pearson, Jeffrey C.; Shumaker, Amy Hirsch; Baden, Lindsey R.; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Daar, Eric S.; Glidden, David, V; Hardy, Erica J.; Johnson, Steven; Li, Jonathan Z.; MacBrayne, Christine; Nakamura, Mari M.; Riley, Laura; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Tien, Phyllis C.; Loveless, Jennifer; Falck-Ytter, Yngve; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
分享 收藏
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial Luetkemeyer, Anne F.; Chew, Kara W.; Lacey, Stuart; Hughes, Michael D.; Harrison, Linda J.; Daar, Eric S.; Eron, Joseph; Fletcher, Courtney V.; Greninger, Alexander L.; Hessinger, Diane; Li, Jonathan Z.; Mailhot, David; Wohl, David; Chayakulkeeree, Methee; Accini Mendoza, Jose Luis; Elistratova, Polina; Makinde, Oluwaseun; Morgan, Gareth; Portsmouth, Simon; Uehara, Takeki; Smith, Davey; Currier, Judith S. 分享 收藏
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies Tixagevimab/cilgavimab 或安慰剂用于 ACTIV-2 研究：安全性、药代动力学及中和抗体和抗药抗体 Ignacio, Rachel A. Bender; Chew, Kara W.; Moser, Carlee; Currier, Judith S.; Eron, Joseph J.; Javan, Arzhang Cyrus; Giganti, Mark J.; Ritz, Justin; Gibbs, Michael; Kouekam, Herve Tchouakam; Esser, Mark T.; Daar, Eric S.; Choudhary, Manish; Deo, Rinki; Fletcher, Courtney, V; Li, Jonathan Z.; Hughes, Michael D.; Smith, Davey; Wohl, David Alain 分享 收藏
Early antiviral CD4+and CD8+Tcells are associated with upper airway clearance of SARS-CoV-2 Ramirez, Sydney I.; Lopez, Paul G.; Faraji, Farhoud; Parikh, Urvi M.; Heaps, Amy; Ritz, Justin; Moser, Carlee; Eron, Joseph J.; Wohl, David; Currier, Judith; Daar, Eric S.; Greninger, Alex; Klekotka, Paul; Grifoni, Alba; Weiskopf, Daniela; Sette, Alessandro; Peters, Bjoern; Hughes, Michael D.; Chew, Kara W.; Smith, Davey M.; Crotty, Shane 分享 收藏
分享 收藏
2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis 美国传染病学会关于新型冠状病毒肺炎管理的2024临床实践指南更新: Anti-SARS-CoV-2中和抗体Pemivibart用于暴露前预防 Bhimraj, Adarsh; Falck-Ytter, Yngve; Kim, Arthur Y.; Li, Jonathan Z.; Baden, Lindsey R.; Johnson, Steven; Shafer, Robert W.; Shoham, Shmuel; Tebas, Pablo; Bedimo, Roger; Cheng, Vincent Chi-Chung; Chew, Kara W.; Chiotos, Kathleen; Daar, Eric S.; Dzierba, Amy L.; Glidden, David, V; Hardy, Erica J.; Martin, Greg S.; Macbrayne, Christine; Nadig, Nandita; Nakamura, Mari M.; Shumaker, Amy Hirsch; Tien, Phyllis; Loveless, Jennifer; Morgan, Rebecca L.; Gandhi, Rajesh T. 分享 收藏
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial 在一项随机安慰剂对照试验中，抗新型冠状病毒单克隆抗体治疗后病毒和症状反弹 Chew, Kara W.; McGinley, Brooke; Moser, Carlee; Li, Jonathan Z.; Evering, Teresa H.; Ritz, Justin; Javan, Arzhang Cyrus; Margolis, David; Wohl, David A.; Hughes, Michael D.; Daar, Eric S.; Currier, Judith S.; Eron, Joseph J.; Smith, Davey M. 分享 收藏
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial 急性新型冠状病毒肺炎后结局，包括参与者报告的长期COVID: ACTIV-2试验中amubarvimab/romlusevimab与安慰剂的比较 Evering, Teresa H.; Moser, Carlee; Jilg, Nikolaus; Ritz, Justin; Wohl, David A.; Li, Jonathan Z.; Margolis, David; Javan, Arzhang Cyrus; Eron, Joseph J.; Currier, Judith S.; Daar, Eric S.; Smith, Davey M.; Hughes, Michael D.; Chew, Kara W. 分享 收藏
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback Bloom, Nathaniel; Ramirez, Sydney, I; Cohn, Hallie; Parikh, Urvi M.; Heaps, Amy; Sieg, Scott F.; Greninger, Alex; Ritz, Justin; Moser, Carlee; Eron, Joseph J.; Bajic, Goran; Currier, Judith S.; Klekotka, Paul; Wohl, David A.; Daar, Eric S.; Li, Jonathan; Hughes, Michael D.; Chew, Kara W.; Smith, Davey M.; Crotty, Shane; Coelho, Camila H. 分享 收藏
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial Chew, Kara W.; Taiwo, Babafemi O.; Moser, Carlee; Daar, Eric S.; Wohl, David Alain; Ritz, Justin; Javan, Arzhang Cyrus; Li, Jonathan Z.; Fischer, William; Greninger, Alexander L.; Bausch, Christoph; Luke, Thomas; Call, Robert; Neytman, Gene; Giganti, Mark J.; Fletcher, Courtney, V; Hughes, Michael D.; Eron, Joseph J.; Currier, Judith S.; Smith, Davey M. 分享 收藏
Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019 新型冠状病毒血浆抗体和核衣壳抗原状态可预测冠状病毒病门诊患者的预后2019 Jilg, Nikolaus; Giganti, Mark J.; Chew, Kara W.; Shaw-Saliba, Katy; Ritz, Justin; Moser, Carlee; Evering, Teresa H.; Daar, Eric S.; Eron, Joseph J.; Currier, Judith S.; Hughes, Michael D.; Lane, H. Cliff; Dewar, Robin; Smith, Davey M.; Li, Jonathan Z. 分享 收藏
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Choudhary, Manish C.; Deo, Rinki; Evering, Teresa H.; Chew, Kara W.; Giganti, Mark J.; Moser, Carlee; Ritz, Justin; Regan, James; Flynn, James P.; Crain, Charles R.; Wohl, David Alain; Currier, Judith S.; Eron, Joseph J.; Margolis, David; Zhu, Qing; Zhon, Lijie; Ya, Li; Greninger, Alexander L.; Hughes, Michael D.; Smith, Davey; Daar, Eric S.; Li, Jonathan Z. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏